Valuation: Dechra Pharmaceuticals

Market Cap 440.36Cr 590.98Cr 517.99Cr 478.8Cr 830.88Cr 57TCr 844.21Cr 5.73TCr 2.24TCr 28TCr 2.22TCr 2.17TCr 96TCr P/E 2022
64.8x
P/E 2023 -150x
Enterprise Value 483.37Cr 648.7Cr 568.58Cr 525.57Cr 912.03Cr 63TCr 926.66Cr 6.28TCr 2.46TCr 31TCr 2.44TCr 2.38TCr 1,05500Cr EV / Sales 2022
5.8x
EV / Sales 2023 6.08x
Free-Float
-
Yield 2022
1.3%
Yield 2023 0.34%
3 years 3,644
Extreme 3644
3,868
5 years 2,473.32
Extreme 2473.323
5,525
10 years 1,225
Extreme 1225
5,525
Manager TitleAgeSince
Chief Executive Officer - 10/06/2024
Director of Finance/CFO 46 03/04/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 46 30/10/2019
Director/Board Member 68 01/12/2016
Director/Board Member 59 01/02/2019
Date Insider Type Main position Quantity % Market Cap.
15/01/24 Free

Chief Financial Officer

2,293 0.0020%
15/01/24 Free

Chief Executive Officer

5,372 0.0047%
15/01/24 Buy

Chief Executive Officer

627 0.0006%

Financials

2022 2023
Net sales 68Cr 91Cr 80Cr 74Cr 128.64Cr 8.82TCr 130.71Cr 886.42Cr 347.48Cr 4.32TCr 343.58Cr 336.09Cr 15TCr 76Cr 102.2Cr 90Cr 83Cr 143.68Cr 9.85TCr 145.99Cr 990.04Cr 388.1Cr 4.82TCr 383.74Cr 375.37Cr 17TCr
Net income 5.82Cr 7.81Cr 6.85Cr 6.33Cr 11Cr 753.19Cr 11Cr 76Cr 30Cr 368.52Cr 29Cr 29Cr 1.27TCr -2.79Cr -3.74Cr -3.28Cr -3.03Cr -5.26Cr -361.06Cr -5.35Cr -36Cr -14Cr -176.66Cr -14Cr -14Cr -608.66Cr
Net Debt 21Cr 28Cr 24Cr 23Cr 39Cr 2.69TCr 40Cr 270.68Cr 106.11Cr 1.32TCr 104.92Cr 102.63Cr 4.54TCr 43Cr 58Cr 51Cr 47Cr 81Cr 5.57TCr 82Cr 559.18Cr 219.2Cr 2.72TCr 216.74Cr 212.01Cr 9.38TCr
Logo Dechra Pharmaceuticals
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Employees
-
Sector
-